US Sunshine Act

Institutional Corruption and Pharmaceutical Policy

The goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption — that is, widespread or systemic practices, usually legal, that undermine an institution’s objectives or integrity. The pharmaceutical industry’s own purposes are often undermined. In addition, pharmaceutical industry funding of election campaigns and lobbying skews the legislative process that sets pharmaceutical policy. Moreover, certain practices have corrupted medical research, the production of medical knowledge, the practice of medicine, drug safety, and the Food and Drug Administration’s oversight of pharmaceutical marketing. As a result, practitioners may think they are using reliable information to engage in sound …

Read More »

Perceptions of conflict of interest: surgeons, internists, and learners compared

Department of Surgery, University of Alberta, 2-590 Edmonton Clinic Health Academy, 11405 87 Ave NW, Edmonton, Alberta, Canada T6G 1C9. cdegara@ualberta.ca Abstract BACKGROUND: Making a conflict of interest declaration is now mandatory at continuing medical education CME accredited events. However, these declarations tend to be largely perfunctory. This study sought to better understand physician perceptions surrounding conflict of interest. METHODS: The same PowerPoint (Microsoft, Canada) presentation was delivered at multiple University of Alberta and Royal College CME-accredited events to surgeons, internists, and learners : After each talk, the audience was invited to complete an anonymous, pretested, and standardized 5-point Likert …

Read More »

Conflict Interest Policies at US Academic Medical Centers : AMSA PharmFree Scorecard 2013

For the past decade, there has been a growing chorus of voices comprised of citizens, politicians and healthcare leaders that has only grown louder in its united call for transparency in an effort to restore the erosion of trust that threatened the foundation of the doctor-patient relationship, as well as the medical profession in general. This erosion has been rooted in both the real and perceived conflicts of interest that have become commonplace between the marketing aspects of industry and the physicians who rely on their life-saving medicines and devices. Medical schools and academic medical centers have played a powerful …

Read More »

Conflict of Interest Policies at Canadian Medical Schools : Too Few, Too Weak

The education of medical students should be based on the best clinical information available, rather than on commercial interests. Previous research looking at university-wide conflict of interest (COI) policies used in Canadian medical schools has shown very poor regulation. An analysis of COI policies was undertaken to document the current policy environment in all 17 Canadian medical schools. This study provides the first comprehensive evaluation of all 17 Canadian medical school-specific COI policies. Our results suggest that the COI policy environment at Canadian medical schools is generally permissive. Policy development is a dynamic process. We therefore encourage all Canadian medical …

Read More »

Transparency in Life Sciences : Addressing the Physician Payments Sunshine Act

Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Along with change come new challenges. The Physician Payments Sunshine Act, and other pending regulatory activity in the sector, are bringing a new era of transparency requirements to an evolving industry. Watch our short video to learn ways life sciences companies are addressing the Sunshine Act and data concerns, new scrutiny for research and development (R&D) and stronger and …

Read More »